Seller record · Telehealth service

Genesis Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. The product pages say partner pharmacies are US-licensed 503A compounding pharmacies, and the terms and answers name none. 1 more criterion also fails; see the table below.

At a glance

Genesis HealthTelehealth service

6/8criteria passed

Price: Semaglutide $175 a month, tirzepatide $225
Sells: compounded semaglutide, compounded tirzepatide, sermorelin injection, and 7 more
FDA letters: 1 on file

Visit Genesis Health See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A Florida telehealth service selling compounded semaglutide and tirzepatide on monthly to annual plans, with sermorelin, NAD+, glutathione and methylene blue, and brand GLP-1 drugs. Physicians of a named medical group prescribe, and the site names no filling pharmacy.

Operating entity Genesis Health International Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Genesis Health's website; Genesis Health's telehealth consent page
S2	Prescription gating	PASS	Genesis Health's weight loss memberships page on its go site
S3	Pharmacy identification	FAIL	Genesis Health's compounded semaglutide product page; Genesis Health's terms and conditions; Genesis Health's frequently asked questions page
S4	Compounding disclosure	PASS	Genesis Health's compounded semaglutide product page; Genesis Health's website
S5	Analytical documentation	FAIL	Genesis Health's frequently asked questions page
S6	Business address	PASS	Genesis Health's website; Genesis Health's contact us page; Genesis Health's privacy policy
S7	Price disclosure	PASS	Genesis Health's compounded semaglutide product page; Genesis Health's compounded tirzepatide product page; Genesis Health's sermorelin injection product page; Genesis Health's NAD+ injection product page; Genesis Health's website
S8	Enforcement status	PASS	fda.gov; letter 721451

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSPrescriptions are issued only after an online consultation with an independent licensed provider, and the telehealth consent names Beluga Health, P.A. and a board-certified physician licensed in the patient's state.Source: Genesis Health's website; Genesis Health's telehealth consent page.

S2PASSThe weight loss start button opens an intake whose first screen asks what reaching a goal weight would mean to the buyer.Source: Genesis Health's weight loss memberships page on its go site.

S3FAILThe site names no filling pharmacy. The product pages say partner pharmacies are US-licensed 503A compounding pharmacies, and the terms and answers name none.Source: Genesis Health's compounded semaglutide product page; Genesis Health's terms and conditions; Genesis Health's frequently asked questions page.

S4PASSEvery product page and the footer state that compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality.Source: Genesis Health's compounded semaglutide product page; Genesis Health's website.

S5FAILThe answers say compounds are tested for potency, sterility and purity, and no certificate of analysis or lot document is published.Source: Genesis Health's frequently asked questions page.

S6PASSGenesis Health International Inc. at 2500 Quantum Lakes Drive, Boynton Beach, FL 33426, printed in the footer of every page and on the contact page. The privacy policy prints the same street and ZIP code with the city spelled Boyton Beach.Source: Genesis Health's website; Genesis Health's contact us page; Genesis Health's privacy policy.

S7PASSCompounded semaglutide at $175 billed monthly, $350 every 3 months, $650 every 6 months or $1,100 a year, shown as $91.67 a month; compounded tirzepatide at $225 billed monthly, $565 every 3 months, $1,050 every 6 months or $1,500 a year. Sermorelin injection at $175 a month, sermorelin tablets at $95, the NAD+ injection at $165, NAD+ nasal spray at $119, NAD+ face cream at $155, glutathione at $110 and methylene blue at $145, each a monthly figure on the annual plan, with first-order discounts of up to $81. Wegovy at $1,299 a month, marked sold out. The home page advertises anti-aging care starting at $112 for the first month, with no later price printed beside it.Source: Genesis Health's compounded semaglutide product page; Genesis Health's compounded tirzepatide product page; Genesis Health's sermorelin injection product page; Genesis Health's NAD+ injection product page; Genesis Health's website.

S8PASSFDA warning letter 721451, February 2026, names Genesis Health International Inc. dba Genesis at 2500 Quantum Lakes Dr, Boynton Beach, Florida, the address the site prints, and alleges that pictured labels present Genesis as the compounder of its semaglutide and tirzepatide and that claims of the same active ingredient as Ozempic, Wegovy and Mounjaro are false or misleading. No FDA action has halted the business, and the company continues to operate.Source: fda.gov; letter 721451.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin injection, sermorelin ODT, NAD+ injection, NAD+ nasal spray, NAD+ face cream, glutathione, methylene blue, brand Wegovy, Ozempic and Zepbound.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione

Enforcement documents on file: 1 warning letter

FDA warning letter 721451, issued February 2026, to Genesis Health International Inc. dba GenesisPictured labels identify Genesis as the compounder of semaglutide and tirzepatide products when it is not, and the site claims the same active ingredient as Ozempic, Wegovy and Mounjaro, which the letter calls false or misleading.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit Genesis Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.